Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colestipol for Erythropoietic Protoporphyria
NCT01422915Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2011
- Primary completion
- Mar 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colestipol in erythropoietic protoporphyria (EPP), sponsored by Brigham and Women's Hospital. Started May 2011; status: completed.
02
Drugs
colestipol
03
Conditions
erythropoietic protoporphyria (EPP)
Beyond the preview
Go deeper on NCT01422915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422915.